The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cerebral ischemia or brain ischemia, is a condition that occurs when there isn't enough blood flow to the brain to meet metabolic demand. This leads to limited oxygen supply or cerebral hypoxia and leads to the death of brain tissue, cerebral infarction, orischemic stroke.
The global Brain Ischemia market size is expected to reach US$ 712.8 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Brain Ischemia in various end use industries. The expanding demands from the Hospital, Clinics and Other, are propelling Brain Ischemia market. Anticoagulation Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antiplatelet segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Brain Ischemia, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Brain Ischemia market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Brain Ischemia market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Brain Ischemia sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Brain Ischemia covered in this report include Bayer AG, H. Lundbeck, Bristol-Myers Squibb, Boehringer Ingelheim, ThromboGenics, Vernalis, Neurotec Pharma and Johnson and Johnson, etc.
The global Brain Ischemia market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Bayer AG
- H. Lundbeck
- Bristol-Myers Squibb
- Boehringer Ingelheim
- ThromboGenics
- Vernalis
- Neurotec Pharma
- Johnson and Johnson
Global Brain Ischemia market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Brain Ischemia market, Segment by Type:
- Anticoagulation Therapy
- Antiplatelet
- Other
Global Brain Ischemia market, by Application:
- Hospital
- Clinics
- Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Brain Ischemia companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Brain Ischemia
1.1 Brain Ischemia Market Overview
1.1.1 Brain Ischemia Product Scope
1.1.2 Brain Ischemia Market Status and Outlook
1.2 Global Brain Ischemia Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Brain Ischemia Market Size by Region (2018-2029)
1.4 Global Brain Ischemia Historic Market Size by Region (2018-2023)
1.5 Global Brain Ischemia Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Brain Ischemia Market Size (2018-2029)
1.6.1 North America Brain Ischemia Market Size (2018-2029)
1.6.2 Europe Brain Ischemia Market Size (2018-2029)
1.6.3 Asia-Pacific Brain Ischemia Market Size (2018-2029)
1.6.4 Latin America Brain Ischemia Market Size (2018-2029)
1.6.5 Middle East & Africa Brain Ischemia Market Size (2018-2029)
2 Brain Ischemia Market by Type
2.1 Introduction
2.1.1 Anticoagulation Therapy
2.1.2 Antiplatelet
2.1.3 Other
2.2 Global Brain Ischemia Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Brain Ischemia Historic Market Size by Type (2018-2023)
2.2.2 Global Brain Ischemia Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Brain Ischemia Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Brain Ischemia Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Brain Ischemia Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Brain Ischemia Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Brain Ischemia Revenue Breakdown by Type (2018-2029)
3 Brain Ischemia Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinics
3.1.3 Other
3.2 Global Brain Ischemia Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Brain Ischemia Historic Market Size by Application (2018-2023)
3.2.2 Global Brain Ischemia Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Brain Ischemia Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Brain Ischemia Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Brain Ischemia Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Brain Ischemia Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Brain Ischemia Revenue Breakdown by Application (2018-2029)
4 Brain Ischemia Competition Analysis by Players
4.1 Global Brain Ischemia Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brain Ischemia as of 2022)
4.3 Date of Key Players Enter into Brain Ischemia Market
4.4 Global Top Players Brain Ischemia Headquarters and Area Served
4.5 Key Players Brain Ischemia Product Solution and Service
4.6 Competitive Status
4.6.1 Brain Ischemia Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer AG
5.1.1 Bayer AG Profile
5.1.2 Bayer AG Main Business
5.1.3 Bayer AG Brain Ischemia Products, Services and Solutions
5.1.4 Bayer AG Brain Ischemia Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer AG Recent Developments
5.2 H. Lundbeck
5.2.1 H. Lundbeck Profile
5.2.2 H. Lundbeck Main Business
5.2.3 H. Lundbeck Brain Ischemia Products, Services and Solutions
5.2.4 H. Lundbeck Brain Ischemia Revenue (US$ Million) & (2018-2023)
5.2.5 H. Lundbeck Recent Developments
5.3 Bristol-Myers Squibb
5.3.1 Bristol-Myers Squibb Profile
5.3.2 Bristol-Myers Squibb Main Business
5.3.3 Bristol-Myers Squibb Brain Ischemia Products, Services and Solutions
5.3.4 Bristol-Myers Squibb Brain Ischemia Revenue (US$ Million) & (2018-2023)
5.3.5 Boehringer Ingelheim Recent Developments
5.4 Boehringer Ingelheim
5.4.1 Boehringer Ingelheim Profile
5.4.2 Boehringer Ingelheim Main Business
5.4.3 Boehringer Ingelheim Brain Ischemia Products, Services and Solutions
5.4.4 Boehringer Ingelheim Brain Ischemia Revenue (US$ Million) & (2018-2023)
5.4.5 Boehringer Ingelheim Recent Developments
5.5 ThromboGenics
5.5.1 ThromboGenics Profile
5.5.2 ThromboGenics Main Business
5.5.3 ThromboGenics Brain Ischemia Products, Services and Solutions
5.5.4 ThromboGenics Brain Ischemia Revenue (US$ Million) & (2018-2023)
5.5.5 ThromboGenics Recent Developments
5.6 Vernalis
5.6.1 Vernalis Profile
5.6.2 Vernalis Main Business
5.6.3 Vernalis Brain Ischemia Products, Services and Solutions
5.6.4 Vernalis Brain Ischemia Revenue (US$ Million) & (2018-2023)
5.6.5 Vernalis Recent Developments
5.7 Neurotec Pharma
5.7.1 Neurotec Pharma Profile
5.7.2 Neurotec Pharma Main Business
5.7.3 Neurotec Pharma Brain Ischemia Products, Services and Solutions
5.7.4 Neurotec Pharma Brain Ischemia Revenue (US$ Million) & (2018-2023)
5.7.5 Neurotec Pharma Recent Developments
5.8 Johnson and Johnson
5.8.1 Johnson and Johnson Profile
5.8.2 Johnson and Johnson Main Business
5.8.3 Johnson and Johnson Brain Ischemia Products, Services and Solutions
5.8.4 Johnson and Johnson Brain Ischemia Revenue (US$ Million) & (2018-2023)
5.8.5 Johnson and Johnson Recent Developments
6 North America
6.1 North America Brain Ischemia Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Brain Ischemia Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Brain Ischemia Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Brain Ischemia Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Brain Ischemia Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Brain Ischemia Market Dynamics
11.1 Brain Ischemia Industry Trends
11.2 Brain Ischemia Market Drivers
11.3 Brain Ischemia Market Challenges
11.4 Brain Ischemia Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
